
PharmaJet and Abnova partner to develop and deliver COVID-19 mRNA Vaccine using Needle-free Injection technology
GOLDEN -- PharmaJet announced that its Needle-free Injection System technology will be used to deliver a messenger RNA (mRNA) vaccine against SARS-CoV-2. The vaccine is being developed by Abnova... Read More
Wednesday May 20, 2020 0 comments

PharmaJet appoints Chris Cappello new CEO
GOLDEN -- PharmaJet today announced the appointment of Chris Cappello to president and CEO. Cappelllo replaces Ron Lowy , who was appointed executive chair of the companys board of directors.... Read More
Wednesday April 29, 2020 0 comments

PharmaJet partners with Immunomic Therapeutics and EpiVax to develop and deliver COVID-19 vaccine
GOLDEN -- PharmaJet , maker of needle-free injection technology, announced its TropisNeedle-free injection system will be used to deliver a COVID-19 vaccine being developed by Immunomic Therapeutics,... Read More
Wednesday April 15, 2020 0 comments

PharmaJet receives $9.6M award to support next-gen needle-free devices
GOLDEN -- PharmaJet , maker of innovative, needle-free injection technology, announced it received a $9.6 million contract award from the Joint Science and Technology Office of the U.S. Defense... Read More
Wednesday March 18, 2020 0 comments